Identifying Optimal Buprenorphine Dosing for Opioid Use Disorder Treatment and Prevention of Overdose

Clinical trial NCT06316830 · RECRUITING

Trial details

NCT number: NCT06316830
Sponsor: Rhode Island Hospital
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Opioid Use Disorder

Start date: 2025-01-06
Primary completion: 2027-08-01
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.